Cholesterol-metabolizing cytochromes P450

Drug Metabolism and Disposition

Volumn 34, Issue 4, 2006, Pages 513-520

  Pikuleva, Irina A ^a  

^a UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

24 HYDROXYCHOLESTEROL; 7ALPHA HYDROXYCHOLESTEROL; CHOLESTEROL; CYTOCHROME P450; CYTOCHROME P450 11A1; CYTOCHROME P450 27A1; CYTOCHROME P450 3A4; CYTOCHROME P450 46A1; CYTOCHROME P450 7A1; LIVER ENZYME; PREGNENOLONE; UNCLASSIFIED DRUG; UNSPECIFIC MONOOXYGENASE;

ARTICLE; CATALYSIS; HOMEOSTASIS; HUMAN; MITOCHONDRION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANIMALS; ANTICHOLESTEREMIC AGENTS; CATALYTIC DOMAIN; CHOLESTEROL; CHOLESTEROL 7-ALPHA-HYDROXYLASE; CHOLESTEROL SIDE-CHAIN CLEAVAGE ENZYME; CYTOCHROME P-450 CYP27A1; CYTOCHROME P-450 ENZYME SYSTEM; HUMANS; LIVER; PROTEIN CONFORMATION; STEROID HYDROXYLASES;

EID: 33645106219     PISSN: 00909556     EISSN: 1521009X     Source Type: Journal    
DOI: 10.1124/dmd.105.008789     Document Type: Article

References (129)

1. Abrahamsson A, Krapivner S, Gustafsson U, Muhrbeck O, Eggertsen G, Johansson I, Persson I, Angelin B, Ingelman-Sundberg M, Bjorkhem I, et al. (2005) Common polymorphisms in the CYP7A1 gene do not contribute to variation in rates of bile acid synthesis and plasma LDL cholesterol concentration. Atherosclerosis 182:37-45.
2. Aguiar M, Masse R, and Gibbs BF (2005) Regulation of cytochrome P450 by posttranslational modification. Drug Metab Rev 37:379-404.
3. Anderson KE, Kok E, and Javitt NB (1972) Bile acid synthesis in man: metabolism of 7a-hydroxycholesterol-14C and 26-hydroxycholesterol-3H. J Clin Investig 51:112-117.
4. Belury MA (2002) Dietary conjugated linoleic acid in health: physiological effects and mechanisms of action. Annu Rev Nutr 22:505-531.
5. Benatti P, Peluso G, Nicolai R, and Calvani M (2004) Polyunsaturated fatty acids: biochemical, nutritional and epigenetic properties. J Am Coll Nutr 23:281-302.
6. Beringer VM, Salen G, and Shefer S (1984) Long-term treatment of cerebrotendinous xanthomatosis with chenodeoxycholic acid. N Engl J Med 311:1649-1652.
7. Bjorkhem I (2002) Do oxysterols control cholesterol homeostasis? J Clin Investig 110:725-730.
8. Bjorkhem I, Boberg KM, and Leitersdorf E (1995) Inborn errors in bile acid biosynthesis and storage of sterols other than cholesterol, in The Metabolic and Molecular Bases of Inherited Disease (Scriver AL, Beaudet AL, Sly WS, Valle D, and Childs B eds) pp 2073-2099, McGraw-Hill, New York.
9. Bodin K, Andersson U, Rystedt E, Ellis E, Norlin M, Pikuleva I, Eggertsen G, Bjorkhem I, and Diczfalusy U (2002) Metabolism of 4 beta-hydroxycholesterol in humans. J Biol Chem 277:31534-31540.
10. Bodin K, Bretillon L, Aden Y, Bertilsson L, Broome U, Einarsson C, and Diczfalusy U (2001) Antiepileptic drugs increase plasma levels of 4beta-hydroxycholesterol in humans: evidence for involvement of cytochrome p450 3A4. J Biol Chem 276:38685-38689.
11. Borroni B, Archetti S, Agosti C, Akkawi N, Brambilla C, Caimi L, Caltagirone C, Di Luca M, and Padovani A (2004) Intronic CYP46 polymorphism along with ApoE genotype in sporadic Alzheimer disease: from risk factors to disease modulators. Neurobiol Aging 25:747-751.
12. Bravo E, Flora L, Cantafora A, De Luca V, Tripodi M, Avella M, and Botham KM (1998) The influence of dietary saturated and unsaturated fat on hepatic cholesterol metabolism and the biliary excretion of chylomicron cholesterol in the rat. Biochim Biophys Acta 1390:134-148.
13. Burns M and Duff K (2002) Cholesterol in Alzheimer's disease and tauopathy. Ann NY Acad Sci 977:367-375.
14. Cali JJ, Hsieh CL, Francke U, and Russell DW (1991) Mutations in the bile acid biosynthetic enzyme sterol 27-hydroxylase underlie cerebrotendinous xanthomatosis. J Biol Chem 266: 7779-7783.
15. Cali JJ and Russell DW (1991) Characterization of human sterol 27-hydroxylase. A mitochondrial cytochrome P-450 that catalyzes multiple oxidation reactions in bile acid biosynthesis. J Biol Chem 266:7774-7778.
16. Calvo RM, Asuncion M, Telleria D, Sancho J, San Millan JL, and Escobar-Morreale HF (2001) Screening for mutations in the steroidogenic acute regulatory protein and steroidogenic factor-1 genes and in CYP11A and dosage-sensitive sex reversal-adrenal hypoplasia gene on the X chromosome, gene-1 (DAX-1), in hyperandrogenic hirsute women. J Clin Endocrinol Metab 86:1746-1749.
17. Chalmers KA, Culpan D, Kehoe PG, Wilcock GK, Hughes A, and Love S (2004) APOE promoter, ACE1 and CYP46 polymorphisms and beta-amyloid in Alzheimer's disease. Neuroreport 15:95-98.
18. Cheema SK, Cikaluk D, and Agellon LB (1997) Dietary fats modulate the regulatory potential of dietary cholesterol on cholesterol 7 alpha-hydroxylase gene expression. J Lipid Res 38:315-323.
19. Chen W and Chiang JY (2003) Regulation of human sterol 27-hydroxylase gene (CYP27A1) by bile acids and hepatocyte nuclear factor 4alpha (HNF4alpha). Gene 313:71-82.
20. Chiang JY (1998) Regulation of bile acid synthesis. Front Biosci 3:d176-193.
21. Chiang JY (2003) Bile acid regulation of hepatic physiology: III. Bile acids and nuclear receptors. Am J Physiol 284:G349-G356.
22. Chung BC, Matteson KJ, Voutilainen R, Mohandas TK, and Miller WL (1986) Human cholesterol side-chain cleavage enzyme, P450scc: cDNA cloning, assignment of the gene to chromosome 15 and expression in the placenta. Proc Natl Acad Sci USA 83:8962-8966.
23. Cohen JC, Cali JJ, Jelinek DF, Mehrabian M, Sparkes RS, Lusis AJ, Russell DW, and Hobbs HH (1992) Cloning of the human cholesterol 7a-hydroxylase gene (CYP7) and localization to chromosome 8q11-q12. Genomics 14:153-161.
24. Combarros O, Infante J, Llorca J, and Berciano J (2004) Genetic association of CYP46 and risk for Alzheimer's disease. Dement Geriatr Cogn Disord 18:257-260.
25. Coon MJ (2005) Cytochrome P450: nature's most versatile biological catalyst. Annu Rev Pharmacol Toxicol 45:1-25.
26. Couture P, Otvos JD, Cupples LA, Wilson PW, Schaefer EJ, and Ordovas JM (1999) Association of the A-204C polymorphism in the cholesterol 7alpha-hydroxylase gene with variations in plasma low density lipoprotein cholesterol levels in the Framingham Offspring Study. J Lipid Res 40:1883-1889.
27. Demaison L and Moreau D (2002) Dietary n-3 polyunsaturated fatty acids and coronary heart disease-related mortality: a possible mechanism of action. Cell Mol Life Sci 59:463-477.
28. Denisov IG, Makris TM, Sligar SG, and Schlichting I (2005) Structure and chemistry of cytochrome P450. Chem Rev 105:2253-2277.
29. Desai P, DeKosky ST, and Kamboh MI (2002) Genetic variation in the cholesterol 24-hydroxylase (CYP46) gene and the risk of Alzheimer's disease. Neurosci Lett 328:9-12.
30. Duane WC and Javitt NB (1999) 27-Hydroxycholesterol: production rates in normal human subjects. J Lipid Res 40:1194-1199.
31. Ellis E, Axelson M, Abrahamsson A, Eggertsen G, Thorne A, Nowak G, Ericzon BG, Bjorkhem I, and Einarsson C (2003) Feedback regulation of bile acid synthesis in primary human hepatocytes: evidence that CDCA is the strongest inhibitor. Hepatology 38:930-938.
32. Fu X, Menke JG, Chen Y, Zhou G, MacNaul KL, Wright SD, Sparrow CP, and Lund EG (2001) 27-Hydroxycholesterol is an endogenous ligand for liver X receptor in cholesterol-loaded cells. J Biol Chem 276:38378-38387.
33. Graham SE and Peterson JA (1999) How similar are P450s and what can their differences teach us? Arch Biochem Biophys 369:24-29.
34. Graham-Lorence S, Amarneh B, White RE, Peterson JA, and Simpson ER (1995) A threedimensional model of aromatase cytochrome P450. Protein Sci 4:1065-1080.
35. Guengerich FP (2005) Human cytochrome P450 enzymes, in Cytochrome P450 (Ortiz de Montellano PR ed) pp 377-530, Kluwer Academic/Plenum Publishers, New York.
36. Hall E, Hylemon P, Vlahcevic Z, Mallonee D, Valerie K, Avadhani N, and Pandak W (2001) Overexpression of CYP27 in hepatic and extrahepatic cells: role in the regulation of cholesterol homeostasis. Am J Physiol 281:G293-G301.
37. Harris WS, Park Y, and Isley WL (2003) Cardiovascular disease and long-chain omega-3 fatty acids. Curr Opin Lipidol 14:9-14.
38. Headlam MJ, Wilce MC, and Tuckey RC (2003) The F-G loop region of cytochrome P450scc (CYP11A1) interacts with the phospholipid membrane. Biochim Biophys Acta 1617:96-108.
39. Hegele RA, Wang J, Harris SB, Brunt JH, Young TK, Hanley AJ, Zinman B, Connelly PW, and Anderson CM (2001) Variable association between genetic variation in the CYP7 gene promoter and plasma lipoproteins in three Canadian populations. Atherosclerosis 154:579-587.
40. Heverin M, Bogdanovic N, Lutjohann D, Bayer T, Pikuleva I, Bretillon L, Diczfalusy U, Winblad B, and Bjorkhem I (2004) Changes in the levels of cerebral and extracerebral sterols in the brain of patients with Alzheimer's disease. J Lipid Res 45:186-193.
41. Hiort O, Holterhus PM, Werner R, Marschke C, Hoppe U, Partsch CJ, Riepe FG, Achermann JC, and Struve D (2005) Homozygous disruption of P450 side-chain cleavage (CYP11A1) is associated with prematurity, complete 46,XY sex reversal and severe adrenal failure. J Clin Endocrinol Metab 90:538-541.
42. Hofman MK, Weggemans RM, Zock PL, Schouten EG, Katan MB, and Princen HM (2004) CYP7A1 A-278C polymorphism affects the response of plasma lipids after dietary cholesterol or cafestol interventions in humans. J Nutr 134:2200-2204.
43. Holmes RP and Kummerow FA (1985) The effect of dietary lipids on the composition and properties of biological membranes, in Structure and Properties of Cell Membranes (Benga G ed) pp 262-280, CRC Press Inc., Boca Raton, FL.
44. Ingelsson M, Jesneck J, Irizarry MC, Hyman BT, and Rebeck GW (2004) Lack of association of the cholesterol 24-hydroxylase (CYP46) intron 2 polymorphism with Alzheimer's disease. Neurosci Lett 367:228-231.
45. Ishibashi S, Schwarz M, Frykman PK, Herz J, and Russell DW (1996) Disruption of cholesterol 7alpha-hydroxylase gene in mice. I. Postnatal lethality reversed by bile acid and vitamin supplementation. J Biol Chem 271:18017-18023.
46. Janowski BA, Grogan MJ, Jones SA, Wisely GB, Kliewer SA, Corey EJ, and Mangelsdorf DJ (1999) Structural requirements of ligands for the oxysterol liver X receptors LXRalpha and LXRbeta. Proc Natl Acad Sci USA 96:266-271.
47. Janowski BA, Willy PJ, Devi TR, Falck JR, and Mangelsdorf DJ (1996) An oxysterol signalling pathway mediated by the nuclear receptor LXR alpha. Nature (Lond) 383:728-731.
48. Javitt NB (2002) 25R,26-Hydroxycholesterol revisited: synthesis, metabolism and biologic roles. J Lipid Res 43:665-670.
49. Johansson A, Katzov H, Zetterberg H, Feuk L, Johansson B, Bogdanovic N, Andreasen N, Lenhard B, Brookes AJ, Pedersen NL, et al. (2004) Variants of CYP46A1 may interact with age and APOE to influence CSF Abeta42 levels in Alzheimer's disease. Hum Genet 114: 581-587.
50. Johnson EF and Stout CD (2005) Structural diversity of human xenobiotic-metabolizing cytochrome P450 monooxygenases. Biochem Biophys Res Commun 338:331-336.
51. Juhasz A, Rimanoczy A, Boda K, Vincze G, Szlavik G, Zana M, Bjelik A, Pakaski M, Bodi N, Palotas A, et al. (2005) CYP46 T/C polymorphism is not associated with Alzheimer's dementia in a population from Hungary. Neurochem Res 30:943-948.
52. Jump DB (2002) The biochemistry of n-3 polyunsaturated fatty acids. J Biol Chem 277:8755-8758.
53. Kabbara A, Payet N, Cottel D, Frigard B, Amouyel P, and Lambert JC (2004) Exclusion of CYP46 and APOM as candidate genes for Alzheimer's disease in a French population. Neurosci Lett 363:139-143.
54. Kajinami K, Brousseau ME, Ordovas JM, and Schaefer EJ (2005) A promoter polymorphism in cholesterol 7alpha-hydroxylase interacts with apolipoprotein E genotype in the LDL-lowering response to atorvastatin. Atherosclerosis 180:407-415.
55. Karam WG and Chiang JY (1994) Expression and purification of human cholesterol 7 alphahydroxylase in Escherichia coli. J Lipid Res 35:1222-1231.
56. Katsumata N, Ohtake M, Hojo T, Ogawa E, Hara T, Sato N, and Tanaka T (2002) Compound heterozygous mutations in the cholesterol side-chain cleavage enzyme gene (CYP11A) cause congenital adrenal insufficiency in humans. J Clin Endocrinol Metab 87:3808-3813.
57. Kolsch H, Lutjohann D, Ludwig M, Schulte A, Ptok U, Jessen F, von Bergmann K, Rao ML, Maier W, and Heun R (2002) Polymorphism in the cholesterol 24S-hydroxylase gene is associated with Alzheimer's disease. Mol Psychiatry 7:899-902.
58. Kovar J, Suchanek P, Hubacek JA, and Poledne R (2004) The A-204C polymorphism in the cholesterol 7alpha-hydroxylase (CYP7A1) gene determines the cholesterolemia responsiveness to a high-fat diet. Physiol Res 53:565-568.
59. Kris-Etherton PM, Harris WS, and Appel LJ (2003) Omega-3 fatty acids and cardiovascular disease: new recommendations from the American Heart Association. Arterioscler Thromb Vasc Biol 23:151-152.
60. Kris-Etherton PM and Yu S (1997) Individual fatty acid effects on plasma lipids and lipoproteins: human studies. Am J Clin Nutr 65:1628S-1644S.
61. Kurushima H, Hayashi K, Shingu T, Kuga Y, Ohtani H, Okura Y, Tanaka K, Yasunobu Y, Nomura K, and Kajiyama G (1995) Opposite effects on cholesterol metabolism and their mechanisms induced by dietary oleic acid and palmitic acid in hamsters. Biochim Biophys Acta 1258:251-256.
62. Lapillonne A, Clarke SD, and Heird WC (2003) Plausible mechanisms for effects of long-chain polyunsaturated fatty acids on growth. J Pediatr 143:S9-S16.
63. Lee M-H, Hazard S, Carpten JD, Yi S, Cohen J, Gerhardt GT, Salen G, and Patel SB (2001) Fine-mapping, mutational analyses and structural mapping of cerebrotendinous xanthomatosis in U.S. pedigrees. J Lipid Res 42:159-169.
64. Li H, Xu G, Shang Q, Pan L, Shefer S, Batta AK, Bollineni J, Tint GS, Keller BT, and Salen G (2004) Inhibition of ileal bile acid transport lowers plasma cholesterol levels by inactivating hepatic farnesoid X receptor and stimulating cholesterol 7 alpha-hydroxylase. Metabolism 53:927-932.
65. Lorincz MT, Rainier S, Thomas D, and Fink JK (2005) Cerebrotendinous xanthomatosis: possible higher prevalence than previously recognized. Arch Neurol 62:1459-1463.
66. Lund E, Andersson O, Zhang J, Babiker A, Ahlborg G, Diczfalusy U, Einarsson K, Sjovall J, and Bjorkhem I (1996) Importance of a novel oxidative mechanism for elimination of intracellular cholesterol in humans. Arterioscler Thromb Vasc Biol 16:208-212.
67. Lund EG, Guileyardo JM, and Russell DW (1999) cDNA cloning of cholesterol 24-hydroxylase, a mediator of cholesterol homeostasis in the brain. Proc Natl Acad Sci USA 96:7238-7243.
68. Lund EG, Kerr TA, Sakai J, Li WP, and Russell DW (1998) cDNA cloning of mouse and human cholesterol 25-hydroxylases, polytopic membrane proteins that synthesize a potent oxysterol regulator of lipid metabolism. J Biol Chem 273:34316-34327.
69. Makishima M (2005) Nuclear receptors as targets for drug development: regulation of cholesterol and bile acid metabolism by nuclear receptors. J Pharmacol Sci 97:177-183.
70. Mast N, Andersson U, Nakayama K, Bjorkhem I, and Pikuleva IA (2004) Expression of human cytochrome P450 46A1 in Escherichia coli: effects of N- and C-terminal modifications. Arch Biochem Biophys 428:99-108.
71. Mast N, Graham SE, Andersson U, Bjorkhem I, Hill C, Peterson J, and Pikuleva IA (2005) Cholesterol binding to cytochrome P450 7A1, a key enzyme in bile acid biosynthesis. Biochemistry 44:3259-3271.
72. Mast N, Norcross R, Andersson U, Shou M, Nakayama K, Bjorkhem I, and Pikuleva IA (2003) Broad substrate specificity of human cytochrome P450 46A1 which initiates cholesterol degradation in the brain. Biochemistry 42:14284-14292.
73. Masumoto O, Ohyama Y, and Okuda K (1988) Purification and characterization of vitamin D 25-hydroxylase from rat liver mitochondria. J Biol Chem 263:14256-14260.
74. Matsuzaki Y, Bouscarel B, Ikegami T, Honda A, Doy M, Ceryak S, Fukushima S, Yoshida S, Shoda J, and Tanaka N (2002) Selective inhibition of CYP27A1 and of chenodeoxycholic acid synthesis in cholestatic hamster liver. Biochim Biophys Acta 1588:139-148.
75. Meir K, Kitsberg D, Alkalay I, Szafer F, Rosen H, Shpitzen S, Avi LB, Staels B, Fievet C, Meiner V, et al. (2002) Human sterol 27-hydroxylase (CYP27) overexpressor transgenic mouse model. Evidence against 27-hydroxycholesterol as a critical regulator of cholesterol homeostasis. J Biol Chem 277:34036-34041.
76. Meunier B, de Visser SP, and Shaik S (2004) Mechanism of oxidation reactions catalyzed by cytochrome p450 enzymes. Chem Rev 104:3947-3980.
77. Michael LF, Schkeryantz JM, and Burris TP (2005) The pharmacology of LXR. Mini Rev Med Chem 5:729-740.
78. Miller WL (1998) Why nobody has P450scc (20,22 desmolase) deficiency. J Clin Endocrinol Metab 83:1399-1400.
79. Mitton JR, Scholan NA, and Boyd GS (1971) The oxidation of cholesterol in rat liver sub-cellular particles. The cholesterol-7-alpha-hydroxylase enzyme system. Eur J Biochem 20:569-579.
80. Moghadasian MH (2004) Cerebrotendinous xanthomatosis: clinical course, genotypes and metabolic backgrounds. Clin Investig Med 27:42-50.
81. Morise A, Serougne C, Gripois D, Blouquit MF, Lutton C, and Hermier D (2004) Effects of dietary alpha linolenic acid on cholesterol metabolism in male and female hamsters of the LPN strain. J Nutr Biochem 15:51-61.
82. Murtazina D, Puchkaev AV, Schein CH, Oezguen N, Braun W, Nanavati A, and Pikuleva IA (2002) Membrane-protein interactions contribute to efficient 27-hydroxylation of cholesterol by mitochondrial cytochrome P450 27A1. J Biol Chem 277:37582-37589.
83. Murtazina DA, Andersson U, Hahn IS, Bjorkhem I, Ansari GA, and Pikuleva IA (2004) Phospholipids modify substrate binding and enzyme activity of human cytochrome P450 27A1. J Lipid Res 45:2345-2353.
84. Myant NB and Mitropoulos KA (1977) Cholesterol 7a-hydroxylase. J Lipid Res 18:135-153.
85. Nakayama K, Puchkaev A, and Pikuleva IA (2001) Membrane binding and substrate access merge in cytochrome P450 7A1, a key enzyme in degradation of cholesterol. J Biol Chem 276:31459-31465.
86. Nebert DW and Russell DW (2002) Clinical importance of the cytochromes P450. Lancet 360:1155-1162.
87. Nicolau VA, Shefer S, Salen G, and Mosbach EH (1974) Determination of hepatic cholesterol 7a-hydroxylase activity in man. J Lipid Res 15:146-151.
88. Oda H, Yamashita H, Kosahara K, Kuroki S, and Nakayama F (1990) Esterified and total 7 alpha-hydroxycholesterol in human serum as an indicator for hepatic bile acid synthesis. J Lipid Res 31:2209-2218.
89. Ohvo-Rekila H, Ramstedt B, Leppimaki P, and Slotte JP (2002) Cholesterol interactions with phospholipids in membranes. Prog Lipid Res 41:66-97.
90. Okuda K, Masumoto O, and Ohyama Y (1988) Purification and characterization of 5 beta-cholestane-3 alpha,7 alpha,12 alpha-triol 27-hydroxylase from female rat liver mitochondria. J Biol Chem 263:18138-18142.
91. Pandak WM, Vlahcevic ZR, Heuman DM, Redford KS, Chiang JY, and Hylemon PB (1994) Effects of different bile salts on steady-state mRNA levels and transcriptional activity of cholesterol 7 alpha-hydroxylase. Hepatology 19:941-947.
92. Papassotiropoulos A, Streffer JR, Tsolaki M, Schmid S, Thal D, Nicosia F, Iakovidou V, Maddalena A, Lutjohann D, Ghebremedhin E, et al. (2003) Increased brain beta-amyloid load, phosphorylated tau and risk of Alzheimer disease associated with an intronic CYP46 polymorphism. Arch Neurol 60:29-35.
93. Papassotiropoulos A, Wollmer MA, Tsolaki M, Brunner F, Molyva D, Lutjohann D, Nitsch RM, and Hock C (2005) A cluster of cholesterol-related genes confers susceptibility for Alzheimer's disease. J Clin Psychiatry 66:940-947.
94. Payne AH and Hales DB (2004) Overview of steroidogenic enzymes in the pathway from cholesterol to active steroid hormones. Endocr Rev 25:947-970.
95. Peterson JA and Graham SE (1998) A close family resemblance: the importance of structure in understanding cytochromes P450. Structure 6:1079-1085.
96. Pikuleva IA (2004) Putative F-G loop is involved in association with the membrane in P450scc (P450 11A1). Mol Cell Endocrinol 215:161-164.
97. Pikuleva IA, Bjorkhem I, and Waterman MR (1997) Expression, purification and enzymatic properties of recombinant human cytochrome P450c27 (CYP27). Arch Biochem Biophys 343:123-130.
98. Pikuleva IA, Puchkaev A, and Bjorkhem I (2001) Putative helix F contributes to regioselectivity of hydroxylation in mitochondrial cytochrome P450 27A1. Biochemistry 40:7621-7629.
99. Puglielli L, Tanzi RE, and Kovacs DM (2003) Alzheimer's disease: the cholesterol connection. Nat Neurosci 6:345-351.
100. Pullinger CR, Eng C, Salen G, Shefer S, Batta AK, Erickson SK, Verhagen A, Rivera CR, Mulvihill SJ, Malloy MJ, et al. (2002) Human cholesterol 7alpha-hydroxylase (CYP7A1) deficiency has a hypercholesterolemic phenotype. J Clin Investig 110:109-117.
101. Raffai R and Weisgraber KH (2003) Cholesterol: from heart attacks to Alzheimer's disease. J Lipid Res 44:1432-1440.
102. Reihner E, Angelin B, Rudling M, Ewerth S, Bjorkhem I, and Einarsson K (1990) Regulation of hepatic cholesterol metabolism in humans: stimulatory effects of cholestyramine on HMG-CoA reductase activity and low density lipoprotein receptor expression in gallstone patients. J Lipid Res 31:2219-2226.
103. Repa JJ and Mangelsdorf DJ (2000) The role of orphan nuclear receptors in the regulation of cholesterol homeostasis. Annu Rev Cell Dev Biol 16:459-481.
104. Russell DW (2003) The enzymes, regulation and genetics of bile acid synthesis. Annu Rev Biochem 72:137-174.
105. Sabine JR (1977) Cholesterol. Marcel Dekker, Inc., New York.
106. Schwarz M, Lund EG, Setchell KD, Kayden HJ, Zerwekh JE, Bjorkhem I, Herz J, and Russell DW (1996) Disruption of cholesterol 7alpha-hydroxylase gene in mice. II. Bile acid deficiency is overcome by induction of oxysterol 7-alpha-hydroxylase. 271:18024-18031.
107. Sewer MB and Waterman MR (2003) ACTH modulation of transcription factors responsible for steroid hydroxylase gene expression in the adrenal cortex. Microsc Res Tech 61:300-307.
108. Shimada T, Yamazaki H, Mimura M, Inui Y, and Guengerich FP (1994) Interindividual variations in human liver cytochrome P-450 enzymes involved in the oxidation of drugs, carcinogens and toxic chemicals: studies with liver microsomes of 30 Japanese and 30 Caucasians. J Pharmacol Exp Ther 270:414-423.
109. Simpson ER and Boyd GS (1967) The cholesterol side-chain cleavage system of bovine adrenal cortex. Eur J Biochem 2:275-285.
110. Song C and Liao S (2000) Cholestenoic acid is a naturally occurring ligand for liver X receptor alpha. Endocrinology 141:4180-4184.
111. Stocco DM (2000) Intramitochondrial cholesterol transfer. Biochim Biophys Acta 1486:184-197.
112. Stocco DM (2001) StAR protein and the regulation of steroid hormone biosynthesis. Annu Rev Physiol 63:193-213.
113. Stone D and Hechter O (1954) Studies on ACTH action in perfused bovine adrenals: site of action of ACTH in corticosteroids. Arch Biochem Biophys 51:457-469.
114. Stubbs CD and Smith AD (1984) The modification of mammalian membrane polyunsaturated fatty acid composition in relation to membrane fluidity and function. Biochim Biophys Acta 779:89-137.
115. Stulnig TM (2003) Immunomodulation by polyunsaturated fatty acids: mechanisms and effects. Int Arch Allergy Immunol 132:310-321.
116. Sudhop T, Lutjohann D, and Bergmann K (2005) Sterol transporters: targets of natural sterols and new lipid lowering drugs. Pharmacol Ther 105:333-341.
117. Tahin QS, Blum M, and Carafoli E (1981) The fatty acid composition of subcellular membranes of rat liver, heart and brain: diet-induced modifications. Eur J Biochem 121:5-13.
118. Tajima T, Fujieda K, Kouda N, Nakae J, and Miller WL (2001) Heterozygous mutation in the cholesterol side chain cleavage enzyme (p450scc) gene in a patient with 46,XY sex reversal and adrenal insufficiency. J Clin Endocrinol Metab 86:3820-3825.
119. Tuckey RC (2005) Progesterone synthesis by the human placenta. Placenta 26:273-281.
120. Turley SD and Dietschy JM (1982) The Liver: Biology and Pathobiology. Raven Press, New York.
121. Verrips A, Hoefsloot LH, Steenbergen GC, Theelen JP, Wevers RA, Gabreels FJ, van Engelen BG, and van den Heuvel LP (2000) Clinical and molecular genetic characteristics of patients with cerebrotendinous xanthomatosis. Brain 123 (Pt 5):908-919.
122. von Wachenfeldt C and Johnson EF (1995) Structures of eukaryotic cytochrome P450 enzymes, in Cytochrome P450: Structure, Mechanism and Biochemistry (Ortiz de Montellano PR ed) pp 183-244, Plenum Press, New York.
123. Wada A, Mathew PA, Barnes HJ, Sanders D, Estabrook RW, and Waterman MR (1991) Expression of functional bovine cholesterol side chain cleavage cytochrome P450 (P450scc) in Escherichia coli. Arch Biochem Biophys 290:376-380.
124. Wang B, Zhang C, Zheng W, Lu Z, Zheng C, Yang Z, Wang L, and Jin F (2004) Association between a T/C polymorphism in intron 2 of cholesterol 24S-hydroxylase gene and Alzheimer's disease in Chinese. Neurosci Lett 369:104-107.
125. Wang J, Freeman DJ, Grundy SM, Levine DM, Guerra R, and Cohen JC (1998) Linkage between cholesterol 7alpha-hydroxylase and high plasma low-density lipoprotein cholesterol concentrations. J Clin Investig 101:1283-1291.
126. Westlind A, Lofberg L, Tindberg N, Andersson TB, and Ingelman-Sundberg M (1999) Interindividual differences in hepatic expression of CYP3A4: relationship to genetic polymorphism in the 5′-upstream regulatory region. Biochem Biophys Res Commun 259:201-205.
127. Wikvall K (1984) Hydroxylations in biosynthesis of bile acids. Isolation of a cytochrome P-450 from rabbit liver mitochondria catalyzing 26-hydroxylation of C27-steroids. J Biol Chem 259:3800-3804.
128. Williams PA, Cosme J, Sridhar V, Johnson EF, and McRee DE (2000) Mammalian microsomal cytochrome P450 monooxygenase: structural adaptations for membrane binding and functional diversity. Mol Cell 5:121-131.
129. Wolozin B, Brown J III, Theisler C, and Silbermann S (2005) The cellular biochemistry of cholesterol and statins: insight into pathophysiology and therapy of Alzheimer's disease. CNS Drug Rev 10:127-146.